Sr One Capital Management, LP Arcellx, Inc. Transaction History
Sr One Capital Management, LP
- $221 Million
- Q1 2025
A detailed history of Sr One Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 2,346,630 shares of ACLX stock, worth $145 Million. This represents 69.67% of its overall portfolio holdings.
Number of Shares
2,346,630
Previous 2,346,630
-0.0%
Holding current value
$145 Million
Previous $179 Million
13.87%
% of portfolio
69.67%
Previous 66.54%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$278 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$247 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$232 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$218 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$188 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.71B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...